NN
Nandakumar Natarajan
The University of Texas Southwestern Medical Center, Complement Technology Inc., University of Madras, Manonmaniam Sundaranar University, The University of Texas Health Science Center at Tyler
Employment
-
The University of Texas Southwestern Medical Center Senior Research Scientist2025 - Present
-
Complement Technology Inc. Scientist R&D2023 - 2024
-
The University of Texas Health Science Center at Tyler Assistant Professor of Research2022 - 2023
-
University of California San Francisco Postdoctoral Research Associate2021 - 2022
-
Clemson University Postdoctoral Research Associate2019 - 2021
-
Ben-Gurion University of the Negev Faculty of Health Sciences Postdoctoral Fellow2013 - 2016
Education
-
University of Madras Ph.D.2007 - 2011
-
Manonmaniam Sundaranar University M.Phil.2002 - 2003
-
University of Madras M.Sc.1999 - 2002
-
University of Madras B.Sc.1996 - 1999
Projects & Funding
Projects & funding information is unavailable.
Publications (41)
- Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies Save
- Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms Save
- Boswellia serrata-mediated zinc oxide nanoparticles-coated cotton fabrics for the wound healing and antibacterial applications against nosocomial pathogens Save
- Green synthesized zinc oxide nanoparticles from Cinnamomum verum bark extract inhibited cell growth and induced caspase-mediated apoptosis in oral cancer KB cells Save
- Influence of Padina gymnospora on Apoptotic Proteins of Oral Cancer Cells—a Proteome-Wide Analysis Save
- Anticancer effect of selenium/chitosan/polyethylene glycol/allyl isothiocyanate nanocomposites against diethylnitrosamine-induced liver cancer in rats Save
- Chitosan-sodium alginate-polyethylene glycol-crocin nanocomposite treatment inhibits esophageal cancer KYSE-150 cell growth via inducing apoptotic cell death Save
- Benzisothiazolone Derivatives Exhibit Cytotoxicity in Hodgkin's Lymphoma Cells through NF-κB Inhibition and are Synergistic with Doxorubicin and Etoposide. Save
- Coral-associated bacterial extracts inhibit cellular NF-κB pathway Save
- Quorum sensing modulators exhibit cytotoxicity in Hodgkin's lymphoma cells and interfere with NF-κB signaling. Save